Literature DB >> 10953349

Homeobox B3, B4, and C6 gene product expression in osteosarcomas as detected by immunocytochemistry.

B Bodey1, B Bodey1, S E Siegel, J V Luck, H E Kaiser.   

Abstract

Osteosarcoma (OS) is a malignant neoplastic disease of the bone, of mesenchymal origin and with considerable morphologic heterogeneity, consisting of malignant stoma with evidence of malignant osteoid, bone and/or cartilage production. The mammalian homeobox (HOX) represents a highly conserved DNA motif of 183 base pairs, encoding the 61 amino acid DNA-binding homeodomain, through which the HOX gene products regulate the transcription of other genes involved in onto- and histogenesis. Re-expression of HOX proteins has been identified in a wide variety of neoplastically transformed cell types and it seems that the HOX genes represent yet another family of oncofetal antigens involved in both normal development and oncogenesis, as well as tumor tissue progression. During this study, the expression pattern of three HOX gene products (HOX-C6, -B3, and -B4) was examined immunocytochemically in human osteosarcoma (OS) tissues. In all observed (16/16) OS cases, HOX-C6 was present in over 90% of the neoplastically transformed cells (+4), demonstrating a high to medium grade (A to B) staining intensity. Similar results were obtained in OS cells for the other two observed proteins (HOX-B3 and -B4; over 90% or +4 and a high to medium grade staining intensity or A and B). The significance of the expression of class I HOX proteins in the pathobiology, diagnosis and prognostication of human OS should be established by further investigations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10953349

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Bisphenol-A induces expression of HOXC6, an estrogen-regulated homeobox-containing gene associated with breast cancer.

Authors:  Imran Hussain; Arunoday Bhan; Khairul I Ansari; Paromita Deb; Samara A M Bobzean; Linda I Perrotti; Subhrangsu S Mandal
Journal:  Biochim Biophys Acta       Date:  2015-02-25

2.  HOXC6 is deregulated in human head and neck squamous cell carcinoma and modulates Bcl-2 expression.

Authors:  Sung-Min Moon; Soo-A Kim; Jung-Hoon Yoon; Sang-Gun Ahn
Journal:  J Biol Chem       Date:  2012-08-15       Impact factor: 5.157

3.  Immunocytochemical detection of HoxD9 and Pbx1 homeodomain protein expression in Chinese esophageal squamous cell carcinomas.

Authors:  De-Bin Liu; Zhen-Dong Gu; Xiao-Zhe Cao; Hong Liu; Ji-You Li
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

4.  Expression pattern of the class I homeobox genes in ovarian carcinoma.

Authors:  Jin Hwa Hong; Jae Kwan Lee; Joong Jean Park; Nak Woo Lee; Kyu Wan Lee; Jung Yeol Na
Journal:  J Gynecol Oncol       Date:  2010-03-31       Impact factor: 4.401

5.  The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways.

Authors:  Carlos S Moreno
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

6.  HOX genes in ovarian cancer.

Authors:  Zoë L Kelly; Agnieszka Michael; Simon Butler-Manuel; Hardev S Pandha; Richard Gl Morgan
Journal:  J Ovarian Res       Date:  2011-09-09       Impact factor: 4.234

7.  Silencing homeobox C6 inhibits colorectal cancer cell proliferation.

Authors:  Meiling Ji; Qingyang Feng; Guodong He; Liangliang Yang; Wentao Tang; Xinyuan Lao; Dexiang Zhu; Qi Lin; Pingping Xu; Ye Wei; Jianmin Xu
Journal:  Oncotarget       Date:  2016-05-17

8.  HOXC6 gene silencing inhibits epithelial-mesenchymal transition and cell viability through the TGF-β/smad signaling pathway in cervical carcinoma cells.

Authors:  Feng Zhang; Chen-Chen Ren; Ling Liu; Yan-Nan Chen; Li Yang; Xiao-An Zhang
Journal:  Cancer Cell Int       Date:  2018-12-12       Impact factor: 5.722

9.  Multitranscriptome analyses of keloid fibroblasts reveal the role of the HIF-1α/HOXC6/ERK axis in keloid development.

Authors:  Qi Wang; Yixiu Zhong; Zhijia Li; Dingheng Zhu; Hongyan Lu; Pingjiao Chen; Changxing Li; Xuebiao Peng; Qian Li; Kang Zeng
Journal:  Burns Trauma       Date:  2022-05-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.